Optimal duration of bladder catheterization after elective caesarean section to prevent urinary tract morbidity: a randomized controlled trial of 12 versus 24 hours. - Trial PACTR202308564052985
Access comprehensive clinical trial information for PACTR202308564052985 through Pure Global AI's free database. This Not Applicable trial is sponsored by Dr Loretta Nnakwe and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Dr Loretta Nnakwe
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
The rate of caesarean section has been on the rise worldwide due to its ability to prevent maternal and foetal morbidity and mortality. However, bladder catheterization during caesarean section can result in urinary tract morbidities. The optimal duration before removal of the catheter after caesarean section remains contentious and current practice is rather customary than global best practice guideline. The aim of this trial is to compare the post-operative morbidities associated with either 12-hour or 24-hour duration of bladder catheterization after elective caesarean section. Specific objectives include the prevalence of urine retention, significant bacturiuria, urinary tract infection and the pattern of post-operative recovery between both groups.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202308564052985
Non-Device Trial